Phase III, Randomized, Placebo-Controlled Study of Docetaxel in Combination With Zibotentan in Patients With Metastatic Castration-Resistant Prostate Cancer
FIZAZI, Karim S, HIGANO, Celestia S, NELSON, Joel B, GLEAVE, Martin, MILLER, Kurt, MORRIS, Thomas, NATHAN, Faith E, MCINTOSH, Stuart, PEMBERTON, Kristine, MOUL, Judd W
Published in Journal of clinical oncology (10.05.2013)
Published in Journal of clinical oncology (10.05.2013)
Get full text
Journal Article
Effect of budesonide/formoterol pressurized metered-dose inhaler on exacerbations versus formoterol in chronic obstructive pulmonary disease: The 6-month, randomized RISE (Revealing the Impact of Symbicort in reducing Exacerbations in COPD) study
Ferguson, Gary T., Tashkin, Donald P., Skärby, Tor, Jorup, Carin, Sandin, Kristina, Greenwood, Michael, Pemberton, Kristine, Trudo, Frank
Published in Respiratory medicine (01.11.2017)
Published in Respiratory medicine (01.11.2017)
Get full text
Journal Article
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
Thatcher, Nick, Chang, Alex, Parikh, Purvish, Rodrigues Pereira, José, Ciuleanu, Tudor, von Pawel, Joachim, Thongprasert, Sumitra, Tan, Eng Huat, Pemberton, Kristine, Archer, Venice, Carroll, Kevin
Published in The Lancet (British edition) (29.10.2005)
Published in The Lancet (British edition) (29.10.2005)
Get full text
Journal Article
Randomized phase 3 trial of IO102-IO103 plus pembrolizumab versus pembrolizumab alone in patients with previously untreated, unresectable, or metastatic melanoma
Svane, Inge Marie, Nair, Santosh M., Puzanov, Igor, Robert, Caroline, Hassel, Jessica Cecile, Sandhu, Shahneen, Vedel Christiansen, Anita, Lowery, Kath, Pemberton, Kristine, Al Hajj, Mohammad, Diede, Scott J., Ehrnrooth, Eva, Eggermont, Alexander M.
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Phase 3, randomized, placebo‐controlled study of zibotentan (ZD4054) in patients with castration‐resistant prostate cancer metastatic to bone
Nelson, Joel B., Fizazi, Karim, Miller, Kurt, Higano, Celestia, Moul, Judd W., Akaza, Hideyuki, Morris, Thomas, McIntosh, Stuart, Pemberton, Kristine, Gleave, Martin
Published in Cancer (15.11.2012)
Published in Cancer (15.11.2012)
Get full text
Journal Article
Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (IRESSA) or docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer
Cufer, Tanja, Vrdoljak, Eduard, Gaafar, Rabab, Erensoy, Inci, Pemberton, Kristine
Published in Anti-cancer drugs (01.04.2006)
Published in Anti-cancer drugs (01.04.2006)
Get more information
Journal Article
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer
Chouaid, Christos, Nathan, Faith, Pemberton, Kristine, Morris, Thomas
Published in Cancer chemotherapy and pharmacology (01.05.2011)
Published in Cancer chemotherapy and pharmacology (01.05.2011)
Get full text
Journal Article
The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials
O'Byrne, Paul M, FitzGerald, J Mark, Zhong, Nanshan, Bateman, Eric, Barnes, Peter J, Keen, Christina, Almqvist, Gun, Pemberton, Kristine, Jorup, Carin, Ivanov, Stefan, Reddel, Helen K
Published in Current controlled trials in cardiovascular medicine (10.01.2017)
Published in Current controlled trials in cardiovascular medicine (10.01.2017)
Get full text
Journal Article
A phase II, randomized, multicenter study to assess the efficacy, safety, and tolerability of zibotentan (ZD4054) in combination with pemetrexed in patients with advanced non-small cell lung cancer
Chouaid, Christos, Nathan, Faith, Pemberton, Kristine, Morris, Thomas
Published in Cancer chemotherapy and pharmacology (14.12.2010)
Published in Cancer chemotherapy and pharmacology (14.12.2010)
Get full text
Journal Article
Analysis of duration of response in oncology trials
Ellis, Stuart, Carroll, Kevin J, Pemberton, Kristine
Published in Contemporary clinical trials (01.07.2008)
Published in Contemporary clinical trials (01.07.2008)
Get full text
Journal Article
Safety and efficacy results from two randomized expansions of a phase I study of a tablet formulation of the PARP inhibitor, olaparib, in ovarian and breast cancer patients with BRCA 1/2 mutations
Molife, L Rhoda, Mateo, Joaquin, McGoldrick, Trevor, Krebs, Matthew, Drew, Yvette, Banerjee, Susana N., Nicum, Shibani, Ranson, Malcolm, Rustin, Gordon J. S., Sessa, Cristiana, Plummer, Ruth, Leunen, Karin, Friedlander, Michael, Swaisland, Helen, Burke, Wendy, McCormack, Peter, Pemberton, Kristine, Tchakov, Ilian, Kaye, Stanley B., Gourley, Charlie
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer : results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer). Commentary
THATCHER, Nick, CHANG, Alex, CARROLL, Kevin, ONN, Amir, HERBST, Roy S, PARIKH, Purvish, RODRIGUES PEREIRA, José, CIULEANU, Tudor, VON PAWEL, Joachim, THONGPRASERT, Sumitra, ENG HUAT TAN, PEMBERTON, Kristine, ARCHER, Venice
Published in The Lancet (British edition) (2005)
Get full text
Published in The Lancet (British edition) (2005)
Journal Article